Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nachbagauer

Showing results (41-50 of 102) with videos related to

Pageof 11
Sort By:
Journal of Virology|June 5, 2020
Enhancing Neuraminidase Immunogenicity of Influenza A Viruses by Rewiring RNA Packaging SignalsAllen Zheng, Weina Sun, Xiaoli Xiong, et al.
Journal of Virology|January 1, 2016
Hemagglutinin Stalk Immunity Reduces Influenza Virus Replication and Transmission in FerretsRaffael Nachbagauer, Matthew S Miller, Rong Hai, et al.
Vaccine|January 22, 2020
Activity of human serum antibodies in an influenza virus hemagglutinin stalk-based ADCC reporter assay correlates with activity in a CD107a degranulation assayVeronika Chromikova, Jessica Tan, Sadaf Aslam, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 3, 2012
Prospective analysis of human cytomegalovirus DNAemia and specific CD8+ T cell responses in lung transplant recipientsL Weseslindtner, H Kerschner, D Steinacher, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 12, 2011
Human cytomegalovirus infection in lung transplant recipients triggers a CXCL-10 responseL Weseslindtner, R Nachbagauer, M Kundi, et al.
Molecular Therapy. Methods & Clinical Development|January 15, 2020
Targeting Antigen to the Surface of EVs Improves the <i>In Vivo</i> Immunogenicity of Human and Non-human Adenoviral Vaccines in MiceCarly M Bliss, Andrea J Parsons, Raffael Nachbagauer, et al.
Molecular Therapy. Methods & Clinical Development|September 6, 2021
Antigen modifications improve nucleoside-modified mRNA-based influenza virus vaccines in miceAlec W Freyn, Matthew Pine, Victoria C Rosado, et al.
Mbio|March 24, 2016
Cryo-electron Microscopy Structures of Chimeric Hemagglutinin Displayed on a Universal Influenza Vaccine CandidateErin E H Tran, Kira A Podolsky, Alberto Bartesaghi, et al.
Vaccines|January 14, 2021
Chimeric Hemagglutinin-Based Live-Attenuated Vaccines Confer Durable Protective Immunity against Influenza A Viruses in a Preclinical Ferret ModelWen-Chun Liu, Raffael Nachbagauer, Daniel Stadlbauer, et al.
The Journal of Infectious Diseases|November 5, 2016
Cross-Reactive and Cross-Neutralizing Activity of Human Mumps Antibodies Against a Novel Mumps Virus From BatsShannon M Beaty, Raffael Nachbagauer, Ariana Hirsh, et al.
Pageof 11

Showing results (41-50 of 102) with videos related to

Sort By:
Pageof 11
Journal of Virology|June 5, 2020
Enhancing Neuraminidase Immunogenicity of Influenza A Viruses by Rewiring RNA Packaging SignalsAllen Zheng, Weina Sun, Xiaoli Xiong, et al.
Journal of Virology|January 1, 2016
Hemagglutinin Stalk Immunity Reduces Influenza Virus Replication and Transmission in FerretsRaffael Nachbagauer, Matthew S Miller, Rong Hai, et al.
Vaccine|January 22, 2020
Activity of human serum antibodies in an influenza virus hemagglutinin stalk-based ADCC reporter assay correlates with activity in a CD107a degranulation assayVeronika Chromikova, Jessica Tan, Sadaf Aslam, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 3, 2012
Prospective analysis of human cytomegalovirus DNAemia and specific CD8+ T cell responses in lung transplant recipientsL Weseslindtner, H Kerschner, D Steinacher, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 12, 2011
Human cytomegalovirus infection in lung transplant recipients triggers a CXCL-10 responseL Weseslindtner, R Nachbagauer, M Kundi, et al.
Molecular Therapy. Methods & Clinical Development|January 15, 2020
Targeting Antigen to the Surface of EVs Improves the <i>In Vivo</i> Immunogenicity of Human and Non-human Adenoviral Vaccines in MiceCarly M Bliss, Andrea J Parsons, Raffael Nachbagauer, et al.
Molecular Therapy. Methods & Clinical Development|September 6, 2021
Antigen modifications improve nucleoside-modified mRNA-based influenza virus vaccines in miceAlec W Freyn, Matthew Pine, Victoria C Rosado, et al.
Mbio|March 24, 2016
Cryo-electron Microscopy Structures of Chimeric Hemagglutinin Displayed on a Universal Influenza Vaccine CandidateErin E H Tran, Kira A Podolsky, Alberto Bartesaghi, et al.
Vaccines|January 14, 2021
Chimeric Hemagglutinin-Based Live-Attenuated Vaccines Confer Durable Protective Immunity against Influenza A Viruses in a Preclinical Ferret ModelWen-Chun Liu, Raffael Nachbagauer, Daniel Stadlbauer, et al.
The Journal of Infectious Diseases|November 5, 2016
Cross-Reactive and Cross-Neutralizing Activity of Human Mumps Antibodies Against a Novel Mumps Virus From BatsShannon M Beaty, Raffael Nachbagauer, Ariana Hirsh, et al.
Pageof 11